Plantarc Bio (Israel) Performance
| PLNT Stock | ILA 220.90 0.00 0.00% |
Plantarc Bio has a performance score of 6 on a scale of 0 to 100. The company holds a Beta of -0.32, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Plantarc Bio are expected to decrease at a much lower rate. During the bear market, Plantarc Bio is likely to outperform the market. Plantarc Bio right now holds a risk of 2.16%. Please check Plantarc Bio mean deviation, downside deviation, information ratio, as well as the relationship between the semi deviation and coefficient of variation , to decide if Plantarc Bio will be following its historical price patterns.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Plantarc Bio are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Plantarc Bio may actually be approaching a critical reversion point that can send shares even higher in January 2026. ...more
Plantarc |
Plantarc Bio Relative Risk vs. Return Landscape
If you would invest 20,460 in Plantarc Bio on September 30, 2025 and sell it today you would earn a total of 1,630 from holding Plantarc Bio or generate 7.97% return on investment over 90 days. Plantarc Bio is generating 0.1764% of daily returns and assumes 2.1609% volatility on return distribution over the 90 days horizon. Simply put, 19% of stocks are less volatile than Plantarc, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Plantarc Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Plantarc Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Plantarc Bio, and traders can use it to determine the average amount a Plantarc Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0816
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PLNT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.16 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Plantarc Bio is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Plantarc Bio by adding it to a well-diversified portfolio.
Plantarc Bio Fundamentals Growth
Plantarc Stock prices reflect investors' perceptions of the future prospects and financial health of Plantarc Bio, and Plantarc Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Plantarc Stock performance.
| Return On Equity | -0.3 | |||
| Return On Asset | -0.18 | |||
| Operating Margin | (82.17) % | |||
| Shares Outstanding | 3.31 M | |||
| Price To Sales | 433.31 X | |||
| Revenue | 64 K | |||
| EBITDA | (5.18 M) | |||
| Cash And Equivalents | 19.77 M | |||
| Cash Per Share | 6.16 X | |||
| Total Debt | 136 K | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 4.73 X | |||
| Cash Flow From Operations | (3.19 M) | |||
| Earnings Per Share | (1.95) X | |||
About Plantarc Bio Performance
By analyzing Plantarc Bio's fundamental ratios, stakeholders can gain valuable insights into Plantarc Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Plantarc Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Plantarc Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
PlantArc Bio Ltd. operates as a biotechnology company for the enhancement of crop productivity and performance for food security. The company was founded in 2014 and is based in Raanana, Israel. PLANTARC BIO is traded on Tel Aviv Stock Exchange in Israel.Things to note about Plantarc Bio performance evaluation
Checking the ongoing alerts about Plantarc Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Plantarc Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 64 K. Net Loss for the year was (4.7 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Plantarc Bio has accumulated about 19.77 M in cash with (3.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.16. | |
| Roughly 58.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Plantarc Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Plantarc Bio's stock is overvalued or undervalued compared to its peers.
- Examining Plantarc Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Plantarc Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Plantarc Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Plantarc Bio's stock. These opinions can provide insight into Plantarc Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Plantarc Stock analysis
When running Plantarc Bio's price analysis, check to measure Plantarc Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Plantarc Bio is operating at the current time. Most of Plantarc Bio's value examination focuses on studying past and present price action to predict the probability of Plantarc Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Plantarc Bio's price. Additionally, you may evaluate how the addition of Plantarc Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world |